Gland Pharma Limited IPO Message Board (Page 20)

As of now it looks one can avoid this GLAND, quite expensive!

Gland Pharma is very expensive - in fact one of the highest even greater than established, reputed players like Abbot, Glaxo, etc. Very very greedy pricing! Nothing left for investors for the next 4 or 5 years! I would strongly recommend stay away!

बहुत महँगा लग रहा है।इस भाव पर ओर बहुत से विकल्प मौजूद हैं। GMP नही है, मतलब किसी का इस शेयर मे interest नही बन रहा है।
शेयर का बाजार भाव सिर्फ उसके काम से निर्धारित नही होता और बहुत से कारण होते है,जिसमे प्रमुख है ओपरेटर।यदि ओपरेटर नही तो भाव कौन बनाएगा।
15 लाख से अधिक एप्लीकेशन (NHI अलग) लगभग सभी को मिलेगा। लिस्टिंग पर बिकवाल ही होगा,खरीदार हाथ रोक लेगा।
जब रिटेल निवेशकों(IPO) को कुछ मिलने की उम्मीद (GMP) ही नही तो क्यों पैसा लगाए?
यह मेरे निजी विचार हैं ,सबका सहमत होना जरूरी नही।मै जब तक 25℅ प्रिमियम न हो नही लगाता।

Chinese company hai iss liye mein toh yeha IPO nahin apply karne wla hoon.

Will decide on 11-11-20 afternoon.

I respect all sentiments. Not to sound contra but to bring in some rationale, Is nt Indian government allowed this company to function in India, SEBI gave permission after checking everything, Anchor investor include Government of Singapore, Nomura, Goldman Sachs, Morgan Stanley, SBI Mutual Fund and Axis Mutual Fund. You see government owned SBI and partial stake also in Axis, and these institutes still investing. All most all pharma companies are doing better in results looks will do so in future as well.

IPO gains or loss all depends on demand. Fundamentals are good, it is costly though. Of course whenever there are tensions these companies will be vilified as sentiments soar. So make your decision based facts in hand, but not on sentiments. Sentiments are temporary (see Titan), fundamental matters in long run.

PLS TELL ME GMP, AND WHERE TO SEE GMP EVERYTIME PLS GUIDE ME

Ask your brokerage house or look here our friends. Post updated GMP

Can anyone please tell me why RII section has more no. of shares in gland pharma IPO.
Please kindly look at the above given subscription box.

In total 100%
In that Anchor investments, AND QIB 50%
HNI 15%
RETAIL 35%

Markets are going up
hope you have earned money
lets check the Subcribtion figures of Gland phrama IPO

I will not apply due to chinese promoters and very high valuations.

Same here, will not apply

Not Applying.....

Anil Singhvi#zeebusiness advised not to participate for listig gain due to chinese promotors and ofs.

Is Satyam Founder Holding Stake in Gland Pharma??

https://www.livemint.com/news/india/sebi-exempts-gland-pharma-s-4-satyam-tagged-shares-from-post-ipo-lock-in/amp-11604477000513.html

@Amit K Singh and HM

Thanks Brother for Clarifying doubt ????????

I will not apply.

Catalent INC is trading at its all Time High at 102
PE 66 x ...

Gland Coming at 25 x FY 22 basis...


Super Timing
Taking Cream out of cake ....

Lisitng will tell..

From ongoing negative sentiments, it seems that retail investors quota will be undersubscribed. It will be interesting to see, what will be the subscription figure of QIB/NII on 11 Nov at 1.30PM..

There will be a lot of learnings from this IPO.

My read is minimum 5 time QIB. Rest is very difficult to predict today.

Anchor list gives idea of interest

In negative sentiments IPO, HNI subscription remain poor. Angel, UTI, equitas are recent examples. And another fact, poor HNI subscription results in negative listing. Moreover HNI lost money in Mazagon dock ipo.

I will be applying for 14 lots. Thus going into HNI category. Better than applying 5 single lots. Dont see risk. Will wait for price trigger of half yearly result. Expected soon post listing

Arun sir
I meant to say 130 shares application in one demat account.

For following reasons.
Say 10 lakh applications apply on an average 1.5 lot. Which means issue is one time subscribed in amount. But allotment process will be
First give 1 lot to all applicant. And then only give residual shares on basis of pro rata applications which means 67% of issue is already alloted
secondly it is looking like that HNI may not subscribe so then you get full allotment. Easier to figure out HNI number as in any issue HNI number is not more than 5000 as opposed to take guess on retail number as retail time keeps on getting extended

I found a good article at value research
https://www.valueresearchonline.com/stories/48677/gland-pharma-ipo-information-analysis
One should read it.

Hello

GMP
22 23
@Rajkot

Last Heard GMP : 20/25

Today Made Low of : 15/20

So GMP not even 2%, definitely it's going to be flat listing. In recent IPOs especially Angel, UTI etc HNI subscription was very low due to flat GMP. Let us see HNI subscription in this IPO.

As per Current Scenario it's an Avoid..

But let's wait till 3rd day 1 P.M, if HNIs & QIBs apply kia acha sa, toh will risk my money with 2-3 lots max.

Else next ipo ma dekhenga..

25 seller

Discounts (60) ..

Kya huva bhai itni frustration kis bat ki hain?
Aesa konsa ipo apply kardiya jisme jyada lose lag gaya?
Gland pharma premium 40-44

Even premium 40 is not much...less than 3% profit. Avoid if this remain situation.